v3.26.1
Business Segments
 3 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Business Segments Business Segments
Segment information has been prepared in accordance with the Segment Reporting topic of FASB ASC 280. Our reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. The primary measure used by our chief operating decision maker ("CODM") to evaluate the performance of our operating segments and allocate resources to these segments is contribution margin, which we define as gross profit less advertising and marketing expenses. Information regarding total assets by operating segment is not provided to our CODM. Our CODM is our Chief Executive Officer.

The tables below summarize information about our reportable segments.
Three Months Ended June 30, 2026
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$226,206 $39,504 $265,710 
Cost of sales110,265 19,257 129,522 
Gross profit115,941 20,247 136,188 
Advertising and marketing28,930 5,738 34,668 
Contribution margin$87,011 $14,509 $101,520 
Other operating expenses49,000 
Operating income$52,520 
* Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment.

Three Months Ended June 30, 2025
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$212,578 $36,952 $249,530 
Cost of sales92,178 17,021 109,199 
Gross profit 120,400 19,931 140,331 
Advertising and marketing28,954 5,983 34,937 
Contribution margin$91,446 $13,948 $105,394 
Other operating expenses33,638 
Operating income$71,756 
* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.

In connection with the acquisition of the OTC Wellness Business, the Company established a new product category, Wellness, Sleep & Other, and renamed certain existing product categories. As a result, certain brands were reclassified among product categories. Prior period amounts have been reclassified to conform to the current period presentation.

The tables below summarize information about our segment revenues from similar product groups.

Three Months Ended June 30, 2026
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Cough, Cold & Allergy$15,628 $5,677 $21,305 
Dermatologicals30,615 2,580 33,195 
Eye & Ear Care28,339 4,639 32,978 
Gastrointestinal47,141 15,061 62,202 
Oral Care18,458 3,900 22,358 
Pain Relief26,225 577 26,802 
Wellness, Sleep & Other12,559 1,768 14,327 
Women's Health47,241 5,302 52,543 
Total segment revenues$226,206 $39,504 $265,710 

Three Months Ended June 30, 2025
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Cough, Cold & Allergy$13,353 $5,654 $19,007 
Dermatologicals27,852 2,257 30,109 
Eye & Ear Care27,781 4,527 32,308 
Gastrointestinal43,696 14,088 57,784 
Oral Care18,154 3,548 21,702 
Pain Relief27,258 1,674 28,932 
Wellness, Sleep & Other4,726 382 5,108 
Women's Health49,758 4,822 54,580 
Total segment revenues$212,578 $36,952 $249,530